A1c (HbA1c) Test: What It Measures, Targets & Clinical Interpretation

Hemoglobin A1c (HbA1c) reflects average blood glucose over the preceding 2–3 months by measuring the percentage of glycated hemoglobin. It is the gold standard for diabetes diagnosis and monitoring.

What It Measures

  • Glucose irreversibly binds to hemoglobin A over RBC lifespan (~120 days)
  • Result = % of total hemoglobin that is glycated
  • Correlates with mean plasma glucose (eAG): eAG (mg/dL) = 28.7 × A1c − 46.7

Diagnostic Thresholds (ADA 2024)

CategoryA1c %eAG (mg/dL)
Normal<5.7%<117
Prediabetes5.7–6.4%117–137
Diabetes≥6.5%≥140

Glycemic Targets (Individualized)

  • Most non-pregnant adults: <7.0% (eAG <154)
  • Stringent (<6.5%): If achievable without hypoglycemia (newly diagnosed, long life expectancy)
  • Less Stringent (<8.0%): Elderly, comorbidities, hypoglycemia unawareness, limited life expectancy

Clinical Caveats

ConditionEffect on A1cAlternative
Hemolytic anemia, blood loss, ESA useFalsely LOWFructosamine, CGM
Iron/B12/folate deficiency, aspleniaFalsely HIGHFructosamine, CGM
Hemoglobin variants (S, C, E, F)Variable interferenceHPLC/boronate affinity assay, CGM
Pregnancy (2nd/3rd tri)Physiologically lowerLower targets (≤6.0%), CGM preferred
CKD / ESRDUnreliableCGM, fructosamine

Monitoring Frequency

  • Stable, at goal: q6 months
  • Therapy change / not at goal: q3 months
  • Pregnancy: q4–6 weeks

A1c is a population-level metric; pair with CGM/time-in-range for individual management.

Medical Billing - Related Articles